Tricyclohexylphosphine → 3-Cyclopropyl-1,5-bis(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one
Reaction equation
I[C:2]1[C:10]2[C:9](=[O:11])[N:8]([CH2:12][O:13][CH2:14][CH2:15][Si:16]([CH3:19])([CH3:18])[CH3:17])[N:7]=[CH:6][C:5]=2[N:4]([CH2:20][O:21][CH2:22][CH2:23][Si:24]([CH3:27])([CH3:26])[CH3:25])[CH:3]=1.Br[C:29]1[C:37]2C(=O)N(COCC[Si](C)(C)C)N=C[C:32]=2N(COCC[Si](C)(C)C)C=1.C1(P(C2CCCCC2)C2CCCCC2)CCCCC1>>[CH:29]1([C:2]2[C:10]3[C:9](=[O:11])[N:8]([CH2:12][O:13][CH2:14][CH2:15][Si:16]([CH3:19])([CH3:18])[CH3:17])[N:7]=[CH:6][C:5]=3[N:4]([CH2:20][O:21][CH2:22][CH2:23][Si:24]([CH3:27])([CH3:26])[CH3:25])[CH:3]=2)[CH2:37][CH2:32]1Participants
4
Reactant 3
Product 1
Procedure
Reaction and post treatment were carried out in the same manner as in Reference example 20-(b) except for using 7.00 g (purity: 78.4%, 10.5 mmol) of 3-iodo-1,5-bis(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one obtained in Reference example 18-(b) in place of 3-bromo-1,5-bis(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one, and using 589 mg (2.10 mmol) of tricyclohexylphosphine in place of butyl-di-1-adamantylphosphine, respectively, whereby 3.60 g of the title compound was obtained as a white solid. (Yield: 79%)
Workup
- customReaction and post treatment
Sources & evidence
- ORD record
- ord-44f09e01d6394827aecd3bfea4d71a61
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450319B2
Reaction notes
Loading…